VedaBio: Funding, Investors & Team (Sep 2026)
VedaBio is a cutting-edge platform that can rapidly detect multiple analytes at the molecular level with exceptional accuracy. This innovative technology revolutionizes molecular biology by eliminating the need for target amplification.
VedaBio has raised $65.0M across 2 funding rounds on record, the most recent a Series A of $25.0M announced in Sep 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
VedaBio Company Profile and Key Stats
Latest funding round on record: Sep 2025.
VedaBio Funding Rounds
VedaBio raised $40.0M in a Series A announced in Oct 2023.
1.9 years later, a Series A of $25.0M was announced in Sep 2025.
VedaBio Founders and Leadership Team
Contact details for the VedaBio team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →VedaBio Funding Compared to Other Biotechnology Startups
VedaBio's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VedaBio in Biotechnology and San Diego
Companies Similar to VedaBio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
VedaBio Funding FAQs
What does VedaBio do?
VedaBio is a cutting-edge platform that can rapidly detect multiple analytes at the molecular level with exceptional accuracy. This innovative technology revolutionizes molecular biology by eliminating the need for target amplification.
How much funding has VedaBio raised?
VedaBio has raised $65.0M across 2 rounds on record. The most recent is a Series A of $25.0M announced in Sep 2025.
When did VedaBio last raise funding?
VedaBio's most recent funding round on record is a Series A of $25.0M, announced in Sep 2025.
Who founded VedaBio?
FundedIQ lists Phil Belgrader (Founder) at VedaBio.
Who is the CEO of VedaBio?
Frédéric Sweeney, PhD is listed as CEO at VedaBio.
Where is VedaBio headquartered?
VedaBio is based in San Diego, California, United States.
How many employees does VedaBio have?
VedaBio is in the 11-50 employee band.
How does VedaBio's funding compare to other Biotechnology startups?
VedaBio's latest round of $25.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's VedaBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VedaBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.